Low- and middle-income countries face many common barriers to implementation of maternal health evidence products  by Puchalski Ritchie, Lisa M. et al.
Journal of Clinical Epidemiology 76 (2016) 229e237Low- and middle-income countries face many common barriers
to implementation of maternal health evidence products
Lisa M. Puchalski Ritchiea,b,c,*, Sobia Khanc, Julia E. Moorec, Caitlyn Timmingsc,
Monique van Lettowd,e, Joshua P. Vogelf, Dina N. Khanf, Godfrey Mbarukug, Mwifadhi Mrishog,
Kidza Mugerwah, Sami Ukai, A. Metin G€ulmezogluf, Sharon E. Strausa,c
aDepartment of Medicine, University of Toronto, RFE 3-805, 200 Elizabeth St., Toronto, Ontario, Canada M5G 2C4
bDepartment of Emergency Medicine, University Health Network, RFE GS-480, 200 Elizabeth St., Toronto, Ontario, Canada M5G 2C4
cLi Ka Shing Knowledge Institute, St. Michael’s Hospital, 30 Bond Street, Toronto, Ontario, Canada M5B 1W8
dDalla Lana School of Public Health, University of Toronto, 155 College St., 6th Floor, Toronto, Ontario, Canada M5T 3M7
eDignitas International, PO Box 1071, Zomba, Malawi
fUNDP/UNFPA/UNICEF/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP)
Department of Reproductive Health and Research, World Health Organization, Avenue Appia 20, Geneva, Switzerland
gIfakara Health Institute, PO Box 78373, Dar es Salaam, Tanzania
hDepartment of Obstetrics and Gynaecology, Makerere University College of Health Sciences, P O Box 7072 Kampala, Uganda
iWorld Health Organization, Pristina Office, Institute of Public Health, University Clinical Centre, St. N€ena Terez€e, Rrethi I Spitalit pn,
10000 Pristina, Kosovo
Accepted 2 February 2016; Published online 27 February 2016AbstractObjectives: To explore similarities and differences in challenges to maternal health and evidence implementation in general across
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Study Design: Secondary analysis of qualitative data.
Setting: Meeting reports andarticles describingprojects undertakenby theauthors infiveLMICson three continentswere analyzed.Projects
focusedon identifying barriers to and facilitators of implementation of evidenceproducts: fiveWorldHealthOrganizationmaternal health guide-
lines, and a knowledge translation strategy to improve adherence to tuberculosis treatment. Data were analyzed using thematic content analysis.
Results: Among identified barriers to evidence implementation, a high degree of commonality was found across countries and clinical
areas, with lack of financial, material, and human resources most prominent. In contrast, few facilitators were identified varied substantially
across countries and evidence implementation products.
Conclusion: By identifying common barriers and areas requiring additional attention to ensure capture of unique barriers and facili-
tators, these findings provide a starting point for development of a framework to guide the assessment of barriers to and facilitators of
maternal health and potentially to evidence implementation more generally in LMICs.  2016 The Authors. Published by Elsevier
Inc. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Failure to effectively implement evidence-informed in-
terventions represents a key obstacle in the progress of
health systems in many low- and middle-income countries
(LMICs) toward achieving the United Nations’ Millennium
Development Goals (MDG) [1]. Although LMICs share
many of the challenges that high-income countries face in
implementing evidence, several features unique to LMICs
add another layer of complexity. In particular, the high
burden of disease and the extreme human and materialess article under the CC BY-NC-ND license (http://creativecommons.org/
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Key findings
 In contrast to the high degree of commonality
among identified barriers to evidence implementa-
tion, the relatively few facilitators that were
identified varied substantially across low- and
middle-income countries and clinical areas.
What this adds to what was known?
 Identification of a list of common barriers and
areas requiring specific attention provides a start-
ing point for ensuring capture of unique barriers
and facilitators to guide evidence implementation
in low- and middle-income countries.
What is the implication and what should change
now?
 Using the suggested approach could help to facili-
tate and expedite assessment of the determinants of
evidence uptake and provide valuable information
to inform mapping interventions to these factors
in health care settings in low- and middle-income
countries.
resource shortages facing LMIC health systems [2,3] com-
pound the need for improved uptake of evidence into policy
and practice, while also complicating implementation
efforts.
Despite some success, improvements in maternal health
remain significantly below MDG targets, with the vast ma-
jority of maternal deaths occurring from avoidable causes
[4]. Evidence-based guidelines exist for common causes
of maternal mortality including: postpartum hemorrhage,
eclampsia, and peripartum infection but are frequently not
optimally implemented [4,5]. Lack of antenatal care and
presence of skilled birth attendants for deliveries have been
identified as important barriers to improving evidence im-
plementation and maternal health outcomes [4]. However,
the root cause of these barriers, such as lack of trained
health care workers, health system capacity and infrastruc-
ture, and community cultural beliefs, may vary substan-
tially in their impact across countries and health care
settings within a given country [6].
An essential first step in designing and tailoring strate-
gies to improve evidence implementation is identifying bar-
riers to and facilitators of such implementation [1]. Barriers
and facilitators are mapped to potential intervention strate-
gies, which are then adapted to the political, cultural, and
organizational context in which they are to be applied
[7,8], providing the basis for a context-appropriate imple-
mentation plan. Despite the importance of assessing bar-
riers and facilitators, doing so can be a resource-intensive
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mentation is not already available in a particular location.
Many of the barriers to and facilitators of evidence im-
plementation in a given LMIC are likely to be shared by
similar settings. As such, lessons learned from the experi-
ence of LMICs that have explored the determinants of ev-
idence uptake and potential strategies to address these
factors may be of benefit to other similar settings. Several
case studies of barrier assessment and implementation plan-
ning have been published [9e13], but to our knowledge,
none have brought together the experience of evidence im-
plementation across a number of LMICs and health condi-
tions to generate a framework of considerations for
intervention development and implementation planning.
Such a framework might help to streamline the assessment
of barriers and facilitators, thereby reducing the resources
needed for this phase while encouraging its completion dur-
ing the implementation planning stage.
The objective of this study was to explore the similar-
ities and differences among perceived challenges to imple-
menting World Health Organization (WHO) maternal
health guidelines across several LMICs and to compare
identified barriers and/or facilitators to maternal health ev-
idence implementation to those in another clinical area,
namely tuberculosis (TB) care, to examine the potential
generalizability of the findings to other clinical areas. The
over goal was to identify both common and unique themes
representing perceived barriers to and facilitators of
behavior change (related to guideline recommendations)
and evidence implementation in LMICs.2. Methods
2.1. Data sources
We conducted a secondary analysis of data from meeting
reports and articles describing projects undertaken by the
authors in five LMICs. Four of these projects were under-
taken as part of the Guideline-driven, Research priorities,
Evidence synthesis, Application of evidence, and Transfer
of knowledge (GREAT) Network. The GREAT Network
uses an evidence-based knowledge translation approach to
support LMICs in implementing evidence-based guidelines
focused on reducing maternal and perinatal morbidity and
mortality. The data included here were taken from meeting
reports and articles from GREAT Network projects con-
ducted in Kosovo (in 2012) [14], Myanmar (in 2014)
[15], Tanzania (in 2014) [16], and Uganda (in 2014) [17].
GREAT Network project activities within each country
focused on implementing one or more of the following
WHO guidelines to improve maternal care, identified as a
priority for implementation by local stakeholders (see
Table 1): augmentation of labor, induction of labor, preven-
tion and treatment of postpartum hemorrhage, prevention
and treatment of pre-eclampsia and eclampsia, and task
shifting in maternal and newborn health.
Table 1. Barriers and facilitators to evidence implementation
Guideline/evidence to be implemented
Kosovo Myanmar Uganda Malawi Tanzania
Postpartum
hemorrhage
Task
shifting
Multiple
guidelinesa
TB
adherence
Multiple
guidelinesa
Health system level
Barriers
Material and financial resources
Lack of equipment/supplies especially in small/rural
centers
x x x x x
Lack of medications especially in small/rural centers x x x x x
Lack of integration/collaboration of health care resources x x
Lack of ability to smoothly transfer patients/or coordinate
care across health system levels
x x x
Inadequate funding of health care x x x x
Lack of funding for supervision/other work-related travel x x
Lack of mechanism to collect high-quality data for
monitoring and evaluation
x x x x
Lack of ability to document and monitor implementation
and current practice
x x
Areas of conflict within country limit ability to implement/
monitor nationally
x x
Human resources
Human resource shortages/workload/high staff turnover x x x x
Unequal distribution of human resources rural/urban x x x
Lack of skill in supervision x x
Lack of supervision/mentorship especially for new
graduates and lower cadres
x x x
Communication/information sharing
Lack of information sharing: new guidelines, trainings
attended by others
x x x
Lack of awareness of guidelines: lead to not ordering or
supplying meds/supplies
x x
Lack of feedback to providers on outcomes that are
monitored
x x x
Lack of communication between providers and policy
makers
x
Lack of trust between clinicians and policy makers x
Policy issues
Lack of clear policy on roles/responsibilities or conflict
between policy and guideline
x x x x
Fear of misuse of meds/meds not approved for use x x
Directly observed therapy (DOTS) guardian system itself
seen as both a barrier and facilitator
x
Facilitators
Financial commitment to training (stipends, opportunities for
refresher training)
x
Pay unpaid volunteer midwives x
Improved monitoring and evaluation, such as use of delivery
books
x x x
Political commitment x
Alignment of guideline with health priorities x
Punitive measures such as legal mandates; fear this could
lead to gaming the system
x
Inclusion of ‘‘aspirational’’ aspects of guideline: keep for
rapid incorporation when able vs. concern inclusion now
is confusing
x
Provider level
Barriers
Training/knowledge/skills
Poor quality of training/inadequate curriculum/lack of
hands on/skill based training
x x x x
Lack of training capacity/time to attend training, including
training of trainers
x x x x x
(Continued )
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Table 1. Continued
Guideline/evidence to be implemented
Kosovo Myanmar Uganda Malawi Tanzania
Postpartum
hemorrhage
Task
shifting
Multiple
guidelinesa
TB
adherence
Multiple
guidelinesa
Lack of baseline education among health care workers
making training difficult
x
Access/awareness
Lack of awareness of the guidelines/evidence x x x
Lack of understanding of how guidelines are developed
(including who is involved): lead not to believe guideline
is trustworthy
x x
Attitudes/beliefs
Fear/concern for potential misuse of guidelines/
medications
x x x
Physician lack of confidence in midwives/other health care
worker cadres
x x
Role confusion due to lack of clear definitions (even when
national definitions available)
x x
Lack of accountability for adherence to guidelines x
lack of communication/interprofessional collaboration,
ethnic/cultural differences, lack of cooperation/blaming
x x x
Facilitators
Suggested incorporate capacity building in the use and
implementation of evidence into undergraduate and
continuing medical education (CME) training
x
Improved ongoing training and monitoring of competencies
necessary for evidence implementation
x
Interprofessional project meeting felt to help communication
between provider groups, suggested continued
engagement through educational initiatives
x
Physician belief in need for training of other health care
worker cadres
x
Evidence that guideline strategies are effective x
Strong leadership/supervision x
Incentives (praise, bonuses) x
Patient/community level
Barriers
Financial resources
Financial constraints at patient level leading to delays in
health care seeking/missed appointments
x x x
Knowledge/beliefs
Lack of knowledge/understanding of reasons for health
advice given
x x
Lack of trust among patients/preference to be seen by
higher-level health care worker
x x
Cultural practices/health seeking behavior/beliefs about
cause of illness
x x x x
Facilitators
High degree of acceptability and support for trained
volunteers in rural areas
x
Community leader trust/support of lower cadres x
a Multiple WHO guidelines maternal health guidelines including: prevention and treatment of postpartum hemorrhage; prevention and treat-
ment of pre-eclampsia and eclampsia; induction of labor; augmentation of labor.
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of the guideline(s) were assessed through a preworkshop
survey, and through an in-country workshop that used focus
groups and small group discussions with relevant stake-
holders, including clinicians, managers, and policy makers
with responsibility for maternal health care. Potential im-
plementation strategies were then discussed to target iden-
tified barriers to and facilitators of implementation ofprioritized recommendations within selected guideline(s).
A fifth project was included to explore the similarities
and difference between barriers and facilitators across
different clinical areas and between implementation of
guidelines and other evidence products. This project, which
took place in Malawi (in 2010) [18], involved assessment of
barriers to and facilitators of evidence implementation from
the TB and general adherence literature to inform the
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care and outcomes among TB patients. The assessment of
barriers to and facilitators of evidence implementation
included field observations and meetings, focus groups,
and interviews with key informants. All the projects specif-
ically inquired about both barriers to and facilitators of ev-
idence implementation, with focus groups in the GREAT
Network projects specifically probing for barriers and facil-
itators at the health system, provider, and patient or com-
munity levels. For more details on these projects, see
Table 1 and reports published to date [14e18].
2.2. Data extraction and synthesis
Data were analyzed using thematic content analysis. We
developed an initial coding framework based on the taxon-
omy of barriers to and facilitators of implementation by
Gravel et al. (2006) [19] and our own experience in con-
ducting these projects. Although some overlap across cate-
gories was evident, barriers and facilitators were
categorized based on the level at which they primarily func-
tion and might be most appropriately addressed. For
example, barriers at the health system level include chal-
lenges from the health unit to national level and may be ad-
dressed through system or policy level interventions.
Provider-level interventions are those impacting on or
occurring within providers that might be addressed by in-
terventions targeting providers individually or in groups.
Finally, patient- or community-level barriers include bar-
riers stemming from issues related to patient/community
health care knowledge, cultural practices, or resource con-
straints that might be addressed through interventions
directly targeting patients or communities.
Two of the investigators reviewed the coding framework
and applied it to data from the five projects. Specifically,
they read meeting reports and articles looking for both pre-
defined and emerging themes. After this initial review, the
coding framework was extended and then used to organize
and code the data into themes and subthemes.
3. Results
Of the barriers to evidence implementation identified
across the participating countries, relatively few (4/35)
were unique to a single country; instead, most barriers were
common to at least two countries and/or clinical areas
(Table 1). Facilitators varied substantially across countries
and evidence implementation projects, with only one facil-
itator (improved monitoring and evaluation systems) identi-
fied in more than one project (see Table 1).
3.1. Common barriers
3.1.1. 1Health system level
Common barriers identified at the health system level
were lack of material and human resources, problems with
communication and information sharing, and policy issues.Lack of material resources, including medications, med-
ical supplies, and equipment, was a key barrier to evidence
implementation in all five projects, particularly in rural and
remote settings. Human resource shortages, involving both
health care providers and skilled supervisors, were also
identified as a key barrier to evidence implementation in
most projects. Resource shortages were characterized as
both actual and relative, with inappropriate distribution of
available resources compounding true shortages, especially
in rural and remote areas. Suboptimal integration and
collaboration within individual health care facilities led
to a scarcity of resources in some departments, although
the necessary materials were available on site in other de-
partments. Another commonly identified system-level bar-
rier was the limited ability or resources to collect high-
quality data to monitor current clinical practice and evi-
dence implementation. Participants attributed this barrier
to a lack of human and material resources for data moni-
toring. Data collection from areas of recent or ongoing
conflict within a country represented a particular challenge.
Lack of health system funding was a commonly identi-
fied barrier to evidence implementation and was thought to
exert its effect through various mechanisms. First, lack of
funding directly affects the procurement of essential medi-
cations, supplies, and equipment, and the ability to
adequately staff health care facilities and conduct important
activities such as data collection and analysis for health sys-
tem monitoring. For example, in Myanmar, implementation
of WHO recommendations on task shifting in maternal and
newborn health was explored, with the goal of shifting spe-
cific tasks from midwives to auxiliary midwives. However,
the auxiliary midwives were unpaid volunteers who had
inadequate resources to perform their duties. They often
paid for medications, replacement equipment, and supplies
by using their own resources, by charging small fees, or by
borrowing from their own family members. Second, lack of
funding for supervisory field visits of health care providers
and other work-related travel further exacerbates human
resource shortages. Third, lack of funding and infrastruc-
ture results in an inability to smoothly transfer patients to
more specialized care settings, which leads to inadequate
coordination of care.
Problems with communication and information sharing
were identified as barriers to implementation in most coun-
tries. Failure to adequately distribute new guidelines to cli-
nicians reportedly led to a lack of awareness of and poor
implementation of guidelines. Failure to communicate with
staff members responsible for ordering supplies contributed
to inadequacy of resources to support guideline implemen-
tation. Participants reported that even when clinical out-
comes data were available, they were not optimally
disseminated to health care providers, who might thus be
unaware that evidence implementation was inadequate
and that change was required.
Policy issues were less frequent, with only one barrier
common to most countries, namely, lack of a policy (or
234 L.M. Puchalski Ritchie et al. / Journal of Clinical Epidemiology 76 (2016) 229e237conflict between guidelines and policy) regarding the scope
of practice, roles, and responsibilities of various team mem-
bers. For example, one group suggested that a policy to sup-
port task shifting the preparation of magnesium sulfate to
physicians when midwives were not available could facili-
tate guideline implementation.3.1.2. Provider level
At the provider level, common barriers to evidence im-
plementation were inadequate training, knowledge, and
skills; lack of access to or awareness of evidence; and atti-
tudes and beliefs.
Inadequate preclinical service training and continuing
education resulting in a lack of knowledge and skills was
an important barrier to evidence implementation in all
countries. In particular, participants commented on inade-
quate or out-of-date curricula, lack of ‘‘hands on’’ or
skills-based training, and lack of time to attend training.
Participants noted that lack of baseline education among
lower-cadre health care workers made both preclinical
and in-service training more difficult.
Lack of access to or awareness of evidence because of
limited Internet access or inadequate distribution of
paper-based evidence resources were identified barriers to
implementation in most countries. Participants in two coun-
tries identified lack of understanding of how evidence prod-
ucts are developed, including how evidence is assessed for
quality, as a barrier. Participants from these two countries
also mentioned that limited understanding about who is
involved in developing guidelines led to a lack of belief
or trust in the evidence products.
Although somewhat less consistently, attitudes and be-
liefs of health care providers were identified as common
barriers to evidence implementation. The most widespread
of these was the belief that the evidence (such as medica-
tions or skills) would be misused. For example, concerns
were raised about the use of oxytocin to augment labor
without confirmation that labor was delayed, particularly
by lower-cadre providers. This belief was associated with
a reported lack of confidence in lower-cadre providers by
physicians. Despite the availability of national definitions
of health care providers’ scopes of practice, role confusion
resulting from task shifting was identified as a barrier to ev-
idence implementation in two countries.
Communication difficulties within and across cadres of
health care workers and lack of interprofessional collabora-
tion as a result of attitudes, ethnic, or work-cultural differ-
ences were identified as barriers to evidence
implementation in two countries. In one country, this report-
edly led to a lack of cooperation or to laying of blame
among providers, with lower-cadre workers blamed for a pa-
tient’s poor condition after transfer to higher-level care. Such
blame in turn led the lower-cadre health workers to transfer
patients earlier, without taking the time to administer
guideline-endorsed treatments, as a way to avoid criticism.3.1.3. Patient and community level
Barriers to evidence implementation at the patient and
community level fell into two categories: lack of financial
resources and patients’ knowledge and beliefs.
Lack of financial resources was identified as a barrier to
evidence implementation in most countries. Financial con-
straints led patients to miss appointments and delay seeking
care. These constraints were relatively pervasive but were
thought to be especially important in rural and remote
regions.
Cultural beliefs about health care and the causes of
illness, patients’ lack of understanding of the reasons for
health advice they received, and patients’ lack of trust of
lower-cadre health care workers or their preference to be
seen by higher-cadre providers were all reported to nega-
tively affect the implementation of evidence. These factors
were perceived to contribute to patients’ delay in or avoid-
ance of seeking appropriate health care.3.2. Unique context-specific barriers
Three unique health system barriers were identified
within the communication and policy themes. The first,
identified in Kosovo only, was a lack of communication
and resultant lack of trust between providers and policy
makers. The second, identified in Uganda and Tanzania,
arose in the context of a specific medication, misoprostol.
The use of this drug is recommended in several WHO
maternal health guidelines; however, as a result of fear that
it might be misused for unsafe termination of pregnancy or
for induction or augmentation of labor without appropriate
patient assessment and dosing, the medication was not
approved in those countries for some guideline indications,
was not ordered, or was not available in the appropriate
dosing formulation. The third, identified in the context of
tuberculosis policy in Malawi, was identified as both a bar-
rier to and facilitator of evidence implementation. Specif-
ically, the requirement for guardian-supervised, directly
observed therapy for outpatient TB care was thought to
be a facilitator in cases where a committed guardian was
available but a barrier when guardians were not committed
or changed frequently. In this latter situation, the result was
inadequate treatment support or conflicting advice to pa-
tients from guardians.
A fourth unique barrier, identified at the provider level in
Uganda, was lack of accountability for evidence implemen-
tation among providers. This barrier was thought to stem in
part from deficiencies in monitoring. No unique barriers to
implementation were identified at the patient and commu-
nity level.3.3. Facilitators
As previously mentioned facilitators varied substantially
across countries and evidence implementation projects,
with only one facilitator (improved monitoring and
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Table 1). This potential facilitator, identified in three coun-
tries, was felt important to promoting evidence implemen-
tation by providing data to inform local efforts to improve
gaps in care and patient outcomes.4. Discussion
A substantial degree of overlap was found among the
barriers to evidence implementation identified in this anal-
ysis across a range of LMICs and clinical areas, with
resource shortages identified as a key barrier to successful
implementation in all projects. With the exception of policy
issues, all the common barriers identified in the study have
been previously reported as barriers to utilization of evi-
dence in other LMICs [9e13]. For example, lack of equip-
ment, supplies, and human resources were identified as
important barriers to optimal malaria care in Tanzania
and Kenya and to prevention of mother-to-child transmis-
sion of human immunodeficiency virus (PMTCT) in
Malawi [9,12,13]. In their review of barriers to implemen-
tation of exclusive breast-feeding guidelines in sub-Saharan
Africa, Eamer et al. [11] identified issues related to infor-
mation sharing with evidence not reaching front line
workers as barriers at both the system and provider levels
and lack of provider knowledge, skills, and training, as
key barriers to guideline implementation. Wasunna et al.
[12] identified inconsistencies in training as a barrier to im-
plementation of malaria treatment guidelines. Attitudes, be-
liefs, and social norms were identified as barriers to malaria
care in Tanzania [9] and to PMTCT in Malawi [13] and
other sub-Saharan countries [10]. Finally, patients’ lack of
financial resources, particularly funding for transportation
to access care, was identified as an important barrier to
PMTCT implementation in several LMICs [9,13]. Together,
these findings suggest that numerous barriers to evidence
implementation are common across a range of LMICs
and clinical areas. To our knowledge, ours is the first study
to identify common and unique barriers and facilitators
across a number of countries and clinical areas. In combi-
nation with the findings of these other studies, our results
may be useful in informing efforts to improve implementa-
tion of evidence in LMICs.
Although relatively few unique barriers were identified
across the projects included in our study, all but one of
them was related to policy or the interaction between policy
makers and health care providers. In some cases, these rep-
resented critical barriers to evidence implementation, which
suggests that specific attention to assessment of policy bar-
riers, through direct engagement of policy makers and other
key stakeholder groups, is warranted in implementation
planning.
As expected from our experience working with LMICs
to improve evidence implementation, far fewer facilitatorsthan barriers were identified, despite specific probing. How-
ever, the lack of commonality among identified facilitators
across LMICs and clinical areas was unexpected, with only
one facilitator (improved monitoring and evaluation sys-
tems) identified in more than one project. From our experi-
ence, several of the facilitators would appear to apply in
more than one setting. A number of identified facilitators
aligned with national campaigns underway at the time of
the assessment, which may have overshadowed stake-
holders’ thoughts about other potential facilitators. In our
literature review, we found few facilitators of evidence im-
plementation in LMICs, which may reflect the specific
focus of many studies on identifying barriers. However,
in keeping with the findings reported here, facilitators re-
ported in previous studies also lacked commonality
[13,18]. We do not know why fewer facilitators than bar-
riers were identified in the projects included in our analysis.
One possibility is that facilitators are more difficult to iden-
tify in the early phase of developing an implementation
plan (before specific targets and strategies have been estab-
lished). Given the potential to leverage context-appropriate
facilitators to support evidence implementation, it will be
important for future researchers to focus on both barriers
and facilitators and to work toward an improved under-
standing of the optimal process and timing for facilitator
assessment, to better inform the development of
interventions.
Several tools are available to guide the assessment of
barriers to and facilitators of evidence implementation
[20e22], but most are based on work conducted in high-
income countries and may therefore be less applicable in
LMIC settings. LMICs may wish to use the list of common
barriers identified in this analysis as a starting point in as-
sessing their own determinants of evidence uptake. In
particular, given the prominence of policy-related issues
among the unique barriers that were identified, it will be
important to focus on policy-specific barriers and to engage
policy makers early in the implementation planning pro-
cess. In view of the high degree of variability among facil-
itators, open-ended questioning followed by specific probes
within the facilitator subthemes identified may be appro-
priate. Beginning with the framework outlined here, may
allow for more efficient assessment of barriers and facilita-
tors and may encourage an understanding of the context of
barriers and facilitators, as well as prioritization of barriers
that can be addressed and facilitators that can be optimized
by implementation strategies.
This approach, with careful attention to unique barriers
and facilitators, may provide valuable information for map-
ping implementation strategies to identified barriers and fa-
cilitators [7]. For example, if a lack of trust in lower-cadre
health care workers among patients is identified as a bar-
rier, use of a local champion could be considered for evi-
dence implementation. Alternatively, if lack of patient
knowledge or understanding is identified as a barrier, use
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volunteers or endorsed by the community leader might
be considered.
This study had several limitations. First, use of project
meeting reports and articles as the units of analysis may
have failed to capture some barriers and facilitators,
particularly those identified as outliers in the primary
studies or those noted by participants outside formal data
collection processes. However, given that the authors of
the present study contributed to both data collection and
preparation of the reports for the primary studies, we
believe it unlikely that any significant barriers or facilita-
tors were overlooked. Second, although both barriers and
facilitators were specifically elicited during the data
collection, it is possible that the barriers facing resource-
constrained LMIC health systems are more salient and
the facilitators more difficult to conceive; more facilitators
might be identified in the context of a specific implemen-
tation strategy. Third, because the assessments were con-
ducted at a preimplementation planning stage for all of
the projects, many of the barriers and facilitators represent
perceived rather than demonstrated challenges and en-
ablers; a somewhat different picture might emerge if bar-
riers and facilitators were reassessed in the context of
ongoing or completed implementation efforts. Fourth,
although a broad range of stakeholders contributed to
the findings of each individual project, rural and remote
areas were generally less well represented, with patients
and community representatives not included. As a result,
important barriers and facilitators specific to rural contexts
and the patient and community level might not have been
captured. Fifth, although all studies collected data using
multiple methods, the data for barriers and facilitators
came predominantly from focus groups; greater emphasis
on other methods might have revealed additional or con-
flicting data. However, it is also possible that additional
assessment methods would have confirmed the focus
group findings, as was the case for the Malawi project,
experience, in which data from interviews, focus groups,
and field observations were largely congruent. Finally, as
four of the five included projects focused on barriers and
facilitators to maternal health guidelines, it is possible that
the results will be applicable only to maternal health
guidelines. However, as seen in Table 1, implementation
of evidence related to TB care in Malawi, shared many
of the same perceived barriers as for the maternal health
guideline projects included. Although further research is
needed, this finding suggests that barrier and facilitator
assessment may share important commonalities in other
clinical areas and for evidence products other than guide-
lines in LMICs.5. Conclusion
The findings presented here provide a starting point for
developing a framework to guide assessment of barriersto and facilitators of evidence implementation in LMIC
health systems. It is hoped that as the framework is
expanded and refined, time and resources may be saved
and assessment of barriers and facilitators improved, with
the provision, in turn, of quality data to guide the mapping
of potential interventions to address identified barriers,
optimize facilitators, and ultimately improve the implemen-
tation of evidence.Acknowledgments
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